Jed Latkin - Net Worth and Insider Trading

Jed Latkin Net Worth

The estimated net worth of Jed Latkin is at least $18 dollars as of 2024-09-20. Jed Latkin is the CEO, COO & CFO of Navidea Biopharmaceuticals Inc and owns about 17,950 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $18. Details can be seen in Jed Latkin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jed Latkin has not made any transactions after 2020-02-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jed Latkin

To

Jed Latkin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jed Latkin owns 2 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) , and Viper Powersports Inc (VPWI) .

Click here to see the complete history of Jed Latkin’s form 4 insider trades.

Insider Ownership Summary of Jed Latkin

Ticker Comapny Transaction Date Type of Owner
NAVB Navidea Biopharmaceuticals Inc 2020-02-20 Interim COO
VPWI Viper Powersports Inc 2012-08-23 director

Jed Latkin Latest Holdings Summary

Jed Latkin currently owns a total of 1 stock. Jed Latkin owns 17,950 shares of Navidea Biopharmaceuticals Inc (NAVB) as of February 20, 2020, with a value of $18.

Latest Holdings of Jed Latkin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NAVB Navidea Biopharmaceuticals Inc 2020-02-20 17,950 0.00 18

Holding Weightings of Jed Latkin


Jed Latkin Form 4 Trading Tracker

According to the SEC Form 4 filings, Jed Latkin has made a total of 1 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Navidea Biopharmaceuticals Inc is the acquisition of 5,000 shares on February 20, 2020, which cost Jed Latkin around $5,400.

Insider Trading History of Jed Latkin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jed Latkin Trading Performance

GuruFocus tracks the stock performance after each of Jed Latkin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jed Latkin is -32.1%. GuruFocus also compares Jed Latkin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jed Latkin within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jed Latkin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jed Latkin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -25.2 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -21.63 LIMIT LIMIT LIMIT LIMIT LIMIT

Jed Latkin Ownership Network

Ownership Network List of Jed Latkin

No Data

Ownership Network Relation of Jed Latkin

Insider Network Chart

Jed Latkin Owned Company Details

What does Navidea Biopharmaceuticals Inc do?

Who are the key executives at Navidea Biopharmaceuticals Inc?

Jed Latkin is the Interim COO of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .

Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Navidea Biopharmaceuticals Inc Insider Transactions

No Available Data

Jed Latkin Mailing Address

Above is the net worth, insider trading, and ownership report for Jed Latkin. You might contact Jed Latkin via mailing address: 152 W. 57th Street, 4th Floor, New York Ny 10019.

Discussions on Jed Latkin

No discussions yet.